CLOSE X

PROCTER & GAMBLE HEALTH LTD.

NSE : PGHLBSE : 500126ISIN CODE : INE199A01012Industry : Pharmaceuticals & DrugsHouse : Merck - MNC
BSE5837.30-12.6 (-0.22 %)
PREV CLOSE ( ) 5849.90
OPEN PRICE ( ) 5833.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2029
TODAY'S LOW / HIGH ( )5728.15 5903.70
52 WK LOW / HIGH ( )4912.3 6107.55
NSE5844.0021 (+0.36 %)
PREV CLOSE( ) 5823.00
OPEN PRICE ( ) 5870.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8241
TODAY'S LOW / HIGH( ) 5733.00 5922.50
52 WK LOW / HIGH ( )4863 6175.5
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 26-04 1967
Management Info
Suresh N Talwar - Chairman Milind Thatte - Managing Director
Registered Office

Address Ground Floor And First Floor P & G Plaza,Cardinal Gracias Road,Chakala, Andheri (East),
Mumbai,
Maharashtra-400099

Phone 022 68669000

Email investorgrievance.im@pg.com

Website www.pghealthindia.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
17Jun Procter & Gamble Health informs about
With reference to the virtual connect with analysts/ institutional inves..
11Jun Procter & Gamble Health informs about
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
09Jun Procter & Gamble Health informs about
Procter & Gamble Health has informed that it attached Company's comm..
10Mar Procter & Gamble Health informs about
Procter & Gamble Health has submitted the notice of the Postal Ballo..
18Feb Procter & Gamble Health informs about
Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated..
Financials
in Millions
QTR Mar 25 ANNUAL 24
Net Profit611.82009.8
Gross Profit 785.3 2733.2
Operating Profit 840.33216.3
Net Sales 3109.911512.6
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
up  35389.40 (1.99%)
M.Cap ( in Cr)75200.00
Astrazeneca Pharma I (BSE)
up  9018.30 (1.35%)
M.Cap ( in Cr)22545.75
Neuland Laboratories (BSE)
up  11984.25 (0.92%)
M.Cap ( in Cr)15375.66
Mankind Pharma (BSE)
up  2386.35 (4.26%)
M.Cap ( in Cr)98491.52
Ajanta Pharma (BSE)
up  2549.05 (1.73%)
M.Cap ( in Cr)31840.72
Shareholding Pattern
PROMOTERS 51.82%
NON-INSTITUTION 27.11%
MUTUAL FUNDS/UTI 10.54%
FI/BANKS/INSURANCE 3.47%
GOVERNMENT 0%
FII 0%
Mf Holdings
Scheme NameHold(%)
UTI MNC Fund-Reg(IDCW)4.70
UTI Healthcare Fund-Reg(IDCW)3.65
Sundaram LT Tax Adv Fund-Sr IV-Reg(G)3.24
Sundaram LT Tax Adv Fund-Sr III-Reg(G)2.99
Sundaram LT Micro Cap Tax Adv Fund-Sr V-Reg(G)2.98
Sundaram LT Micro Cap Tax Adv Fund-Sr VI-Reg(G)2.89
Sundaram LT Micro Cap Tax Adv Fund-Sr III-Reg(G)2.78
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors